Dietary Factors and Biomarkers Involved in the Methylenetetrahydrofolate Reductase Genotype-Colorectal Adenoma Pathway

Gastroenterology

Volumn 131, Issue 6, 2006, Pages 1706-1716

  Martínez, María Elena ^a,c   Thompson, Patricia ^a,c   Jacobs, Elizabeth T ^a,c   Giovannucci, Edward ^e,f   Jiang, Ruiyun ^a   Klimecki, Walt ^d   Alberts, David S ^a,b,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DNA; FOLIC ACID; HOMOCYSTEINE; MULTIVITAMIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; COLORECTAL ADENOMA; DIET; DNA METHYLATION; FEMALE; FOLATE METABOLISM; FOLIC ACID BLOOD LEVEL; GENE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MTHFR GENE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VITAMIN SUPPLEMENTATION;

EID: 33845608177     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.09.010     Document Type: Article

References (79)

1. Sanjoaquin M.A., Allen N., Couto E., Roddam A.W., and Key T.J. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 113 (2005) 825-828
2. Glynn S.A., Albanes D., Pietinen P., Brown C.C., Rautalahti M., Tangrea J.A., Gunter E.W., Barrett M.J., Virtamo J., and Taylor P.R. Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol Biomarkers Prev 5 (1996) 487-494
3. Kato I., Dnistrian A.M., Schwartz M., Toniolo P., Koenig K., Shore R.E., Akhmedkhanov A., Zeleniuch-Jacquotte A., and Riboli E. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer 79 (1999) 1917-1921
4. Martinez M.E., Henning S.M., and Alberts D.S. Folate and colorectal neoplasia: relationship between plasma and dietary markers of folate and adenoma recurrence. Am J Clin Nutr 79 (2004) 691-697
5. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., Wickramasinghe S.N., Everson R.B., and Ames B.N. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 94 (1997) 3290-3295
6. Duthie S.J. Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 55 (1999) 578-592
7. Goyette P., Sumner J., Milos R., Duncan A., Rosenblatt D., Matthews R., and Rozen R. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 7 (1994) 195-200
8. van den Put N.M.J., Steegers-Theunissen R.P.M., Frosst P., Trijbels F.J.M., Eskes T.K.A.B., van den Heuvel L.P., Mariman E.C.M., den Heyer M., Rosen R., and Blom H.J. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346 (1995) 1070-1071
9. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., Selhub J., and Rozen R. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93 (1996) 7-9
10. Blom H.J. Genetic determinants of hyperhomocysteinaemia: the roles of cystathionine beta-synthase and 5,10-methylenetetrahydrofolate reductase. Eur J Pediatr 159 Suppl3 (2000) S208-S212
11. Rozen R. Genetic modulation of homocysteinemia. Semin Thromb Hemost 26 (2000) 255-261
12. Kono S., and Chen K. Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci 96 (2005) 535-542
13. van der Put N.M., Gabreels F., Stevens E.M., Smeitink J.A., Trijbels F.J., Eskes T.K., van den Heuvel L.P., and Blom H.J. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?. Am J Hum Genet 62 (1998) 1044-1051
14. Weisberg I., Tran P., Christensen B., Sibani S., and Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 64 (1998) 169-172
15. Chango A., Potier De Courcy G., Boisson F., Guilland J.C., Barbe F., Perrin M.O., Christides J.P., Rabhi K., Pfister M., Galan P., Hercberg S., and Nicolas J.P. 5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort. Br J Nutr 84 (2000) 891-896
16. Friedman G., Goldschmidt N., Friedlander Y., Ben-Yehuda A., Selhub J., Babaey S., Mendel M., Kidron M., and Bar-On H. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 129 (1999) 1656-1661
17. Friso S., Girelli D., Trabetti E., Stranieri C., Olivieri O., Tinazzi E., Martinelli N., Faccini G., Pignatti P.F., and Corrocher R. A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: relationships with C677T polymorphism and homocysteine/folate metabolism. Clin Exp Med 2 (2002) 7-12
18. Giovannucci E., Chen J., Smith-Warner S.A., Rimm E.B., Fuchs C.S., Palomeque C., Willett W.C., and Hunter D.J. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 12 (2003) 970-979
19. Ma J., Stampfer M.J., Giovannucci E., Artigas C., Hunter D.J., Fuchs C., Willett W.C., Selhub J., Hennekens C.H., and Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions and risk of colorectal cancer. Cancer Res 57 (1997) 1098-1102
20. Slattery M.L., Potter J.D., Samowitz W., Schaffer D., and Leppert M. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 8 (1999) 513-518
21. Levine A.J., Siegmund K.D., Ervin C.M., Diep A., Lee E.R., Frankl H.D., and Haile R.W. The methylenetetrahydrofolate reductase 677C->T polymorphism and distal colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 9 (2000) 657-663
22. Le Marchand L., Wilkens L.R., Kolonel L.N., and Henderson B.E. The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 14 (2005) 1198-1203
23. Ulvik A., Evensen E.T., Lien E.A., Hoff G., Vollset S.E., Majak B.M., and Ueland P.M. Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. Am J Med Genet 101 (2001) 246-254
24. Boyapati S.M., Bostick R.M., McGlynn K.A., Fina M.F., Roufail W.M., Geisinger K.R., Hebert J.R., Coker A., and Wargovich M. Folate intake, MTHFR C677T polymorphism, alcohol consumption, and risk for sporadic colorectal adenoma (United States). Cancer Causes Control 15 (2004) 493-501
25. Ulrich C.M., Kampman E., Bigler J., Schwartz S.M., Chen C., Bostick R., Fosdick S., Beresford S.A.A., Yasui Y., and Potter J.D. Colorectal adenomas and the C677T MTHFR Polymorphism: evidence for gene-environment interaction?. Cancer Epidemiol Biomarkers Prev 8 (1999) 659-668
26. Hillman R.S., and Steinberg S.E. The effects of alcohol on folate metabolism. Annu Rev Med 33 (1982) 345-354
27. Ma J., Stampfer M.J., Giovannucci E., Artigas C., Hunter D.J., Fuchs C., Willett W.C., Selhub J., Hennekens C.H., and Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57 (1997) 1098-1102
28. Giovannucci E., Chen J., Smith-Warner S.A., Rimm E.B., Fuchs C.S., Palomeque C., Willett W.C., and Hunter D.J. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 12 (2003) 970-979
29. Chen J., Giovannucci E., Kelsey K., Rimm E.B., Stampfer M.J., Colditz G.A., Spiegelman D., Willett W.C., and Hunter D.J. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 56 (1996) 4862-4864
30. Keku T., Millikan R., Worley K., Winkel S., Eaton A., Biscocho L., Martin C., and Sandler R. 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev 11 (2002) 1611-1621
31. Yin G., Kono S., Toyomura K., Hagiwara T., Nagano J., Mizoue T., Mibu R., Tanaka M., Kakeji Y., Maehara Y., Okamura T., Ikejiri K., Futami K., Yasunami Y., Maekawa T., Takenaka K., Ichimiya H., and Imaizumi N. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci 95 (2004) 908-913
32. Hirose M., Kono S., Tabata S., Ogawa S., Yamaguchi K., Mineshita M., Hagiwara T., Yin G., Lee K.Y., Tsuji A., and Ikeda N. Genetic polymorphisms of methylenetetrahydrofolate reductase and aldehyde dehydrogenase 2, alcohol use and risk of colorectal adenomas: Self-Defense Forces Health Study. Cancer Sci 96 (2005) 513-518
33. van den Donk M., Buijsse B., van den Berg S.W., Ocke M.C., Harryvan J.L., Nagengast F.M., Kok F.J., and Kampman E. Dietary intake of folate and riboflavin, MTHFR C677T genotype, and colorectal adenoma risk: a Dutch case-control study. Cancer Epidemiol Biomarkers Prev 14 (2005) 1562-1566
34. Martínez M.E.G.E., Jiang R., Henning S.M., Smith-Warner S., Jacobs E.T., Thompson P., and Alberts D.S. Folate fortification of the US food supply, plasma folate, homocysteine, and colorectal adenoma recurrence. Int J Cancer 119 (2006) 1440-1446
35. Martínez M.E., Reid M.E., Guillén-Rodríguez J., Marshall J.R., Sampliner R., Aickin M., Ritenbaugh C., van Leeuwen B., Mason-Liddil N., Giuliano A., Vargas P.A., and Alberts D.S. Design and baseline characteristics of study participants in the Wheat Bran Fiber trial. Cancer Epidemiol Biomarkers Prev 7 (1998) 813-816
36. Alberts D.S., Martinez M.E., Roe D.J., Guillen-Rodriguez J.M., Marshall J.R., van Leeuwen J.B., Reid M.E., Ritenbaugh C., Vargas P.A., Bhattacharyya A.B., Earnest D.L., and Sampliner R.E. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med 342 (2000) 1156-1162
37. Alberts D.S., Martínez M.E., Hess L.S., Einspahr J.G., Green S.B., Bhattacharyya A.K., Guillen J., Krutzsch M., Batta A.K., Salen G., Fales L., Koonce K., Parish D., Clouser M., Roe D., and Lance P. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 97 (2005) 846-853
38. Ritenbaugh C., Aickin M., Taren D., Teufel N., Graver E., Woolf K., and Alberts D.S. Use of a food frequency questionnaire to screen for dietary eligibility in a randomized cancer prevention phase III trial. Cancer Epidemiol Biomarkers Prev 6 (1997) 347-354
39. Martinez M.E., Marshall J.R., Graver E., Whitacre R.C., Woolf K., Ritenbaugh C., and Alberts D.S. Reliability and validity of a self-administered food frequency questionnaire in a chemopreventive trial of adenoma recurrence. Cancer Epidemiol Biomarkers Prev 8 (1999) 941-946
40. Kuo K., Still R., Cale S., and McDowell I. Standardization (external and internal) of HPLC assay for plasma homocysteine. Clin Chem 43 (1997) 1653-1655
41. Martinez M.E., Sampliner R., Marshall J.R., Bhattacharyya A.B., Reid M.E., and Alberts D.S. Adenoma characteristics as risk factors for recurrence of advanced adenomas. Gastroenterology 120 (2001) 1077-1083
42. Hosmer D.W., and Lemeshow S. Applied logistic regression (2000), John Wiley & Sons, New York, NY
43. Pitkin R.M., et al. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin b6, folate, vitamin b12, pantothenic acid, biotin, and choline (1998), National Academy Press, Washington, DC
44. Herbert V. Making sense of laboratory tests of folate: folate requirements to sustain normality. Am J Hematol 26 (1987) 199-207
45. Selhub J., Jacques P.F., Bostom A.G., D'Agostino R.B., Wilson P.W.F., Belanger A.J., O'Leary D.H., Wolf P.A., Schaefer E.J., and Rosenberg I.H. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 332 (1995) 286-291
46. Clarke R., Daly L., Robinson D., et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324 (1991) 1149-1155
47. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R., Wilson P.W., and Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 14 (2002) 476-483
48. Wang L., Miao X., Tan W., Lu X., Zhao P., Zhao X., Shan Y., Li H., and Lin D. Genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase and risk of pancreatic cancer. Clin Gastroenterol Hepatol 3 (2005) 743-751
49. Shen H., Newmann A.S., Hu Z., Zhang Z., Xu Y., Wang L., Hu X., Guo J., Wang X., and Wei Q. Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: a case-control analysis in China. Oncol Rep 13 (2005) 355-360
50. Lacasana-Navarro M., Galvan-Portillo M., Chen J., Lopez-Cervantes M., and Lopez-Carrillo L. Methylenetetrahydrofolate reductase 677C>T polymorphism and gastric cancer susceptibility in Mexico. Eur J Cancer 42 (2006) 528-533
51. Wang L.D., Guo R.F., Fan Z.M., He X., Gao S.S., Guo H.Q., Matsuo K., Yin L.M., and Li J.L. Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus 18 (2005) 177-184
52. Li D., Ahmed M., Li Y., Jiao L., Chou T.H., Wolff R.A., Lenzi R., Evans D.B., Bondy M.L., Pisters P.W., Abbruzzese J.L., and Hassan M.M. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 14 (2005) 1470-1476
53. Sarbia M., Geddert H., Kiel S., Kandemin Y., Schulz W.A., Vossen S., Zotz R.D., Willers R., Baldus S.E., Schneider P.M., and Gabbert H.E. Methylenetetrahydrofolate reductase C677T polymorphism and risk of adenocarcinoma of the upper gastrointestinal tract. Scand J Gastroenterol 40 (2005) 109-111
54. Devlin A.M., Arning E., Bottiglieri T., Faraci F.M., Rozen R., and Lentz S.R. Effect of MTHFR genotype on diet-induced hyperhomocysteinemia and vascular function in mice. Blood 103 (2004) 2624-2629
55. Chen J., Giovannucci E.L., and Hunter D.J. MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among U.S. men and women: an example of gene-environment interactions in colorectal tumorigenesis. J Nutr 129 (1999) 560S-564S
56. Kim Y.I. Role of folate in colon cancer development and progression. J Nutr 133 (2003) S3731-S3739
57. Min mouse. Cancer Res 60 (2000) 5434-5440
58. Issa J.P., and Baylin S.B. Epigenetics and human disease. Nat Med 2 (1996) 281-282
59. Laird P.W. The power and the promise of DNA methylation markers. Nat Rev Cancer 3 (2003) 253-266
60. Kumar J., Das S.K., Sharma P., Karthikeyan G., Ramakrishnan L., and Sengupta S. Homocysteine levels are associated with MTHFR A1298C polymorphism in Indian population. J Hum Genet 50 (2005) 655-663
61. Friso S., Girelli D., Trabetti E., Olivieri O., Guarini P., Pignatti P.F., Corrocher R., and Choi S.W. The MTHFR 1298A>C polymorphism and genomic DNA methylation in human lymphocytes. Cancer Epidemiol Biomarkers Prev 14 (2005) 938-943
62. Krajinovic M., Lemieux-Blanchard E., Chiasson S., Primeau M., Costea I., and Moghrabi A. Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia. Pharmacogenomics J 4 (2004) 66-72
63. Chen J., Giovannucci E., Kelsey K., Rimm E.B., Stampfer M.J., Colditz G.A., Spiegelman D., Willett W.C., and Hunter D.J. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 56 (1996) 4862-4864
64. Le Marchand L., Donlon T., Hankin J.H., Kolonel L.N., Wilkens L.R., and Seifried A. B-vitamin intake, metabolic genes, and colorectal cancer risk (United States). Cancer Causes Control 13 (2002) 239-248
65. Levine A.J., Siegmund K.D., Ervin C.M., Diep A., Lee E.R., Frankl H.D., and Haile R.W. The methylenetetrahydrofolate reductase 677C-->T polymorphism and distal colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 9 (2000) 657-663
66. Chen J., Giovannucci E., Hankinson S.E., Ma J., Willett W.C., Spiegelman D., Kelsey K.T., and Hunter D.J. A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis 19 (1998) 2129-2132
67. Cho E., Smith-Warner S.A., Ritz J., van den Brandt P.A., Colditz G.A., Folsom A.R., Freudenheim J.L., Giovannucci E., Goldbohm R.A., Graham S., Holmberg L., Kim D.H., Malila N., Miller A.B., Pietinen P., Rohan T.E., Sellers T.A., Speizer F.E., Willett W.C., Wolk A., and Hunter D.J. Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140 (2004) 603-613
68. Castro R., Rivera I., Blom H.J., Jakobs C., and de Almeida I.T. Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview. J Inherit Metab Dis 29 (2006) 3-20
69. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J.H., den Heijer M., Kluijtmans L.A.J., van den Heuve L.P., and Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
70. Engbersen A.M., Franken D.G., Boers G.H., Stevens E.M., Trijbels F.J., and Blom H.J. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 56 (1995) 142-150
71. Cronin S., Furie K.L., and Kelly P.J. Dose-related association of MTHFR 677T allele with risk of ischemic stroke: evidence from a cumulative meta-analysis. Stroke 36 (2005) 1581-1587
72. Meleady R., Ueland P.M., Blom H., Whitehead A.S., Refsum H., Daly L.E., Vollset S.E., Donohue C., Giesendorf B., Graham I.M., Ulvik A., Zhang Y., and Bjorke Monsen A.L. Thermolabile methylenetetrahydrofolate reductase, homocysteine, and cardiovascular disease risk: the European Concerted Action Project. Am J Clin Nutr 77 (2003) 63-70
73. Refsum H., Smith A.D., Ueland P.M., Nexo E., Clarke R., McPartlin J., Johnston C., Engbaek F., Schneede J., McPartlin C., and Scott J.M. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 50 (2004) 3-32
74. Jacques P.F., Bostom A.G., Wilson P.W., Rich S., Rosenberg I.H., and Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 73 (2001) 613-621
75. Selhub J., Jacques P.F., Wilson P.W.F., Rush D., and Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270 (1993) 2693-2698
76. Yi P., Melnyk S., Pogribna M., Pogribny I.P., Hine R.J., and James S.J. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 275 (2000) 29318-29323
77. James S.J., Melnyk S., Pogribna M., Pogribny I.P., and Caudill M.A. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 132 (2002) 2361S-2366S
78. Loehrer F.M., Tschopl M., Angst C.P., Litynski P., Jager K., Fowler B., and Haefeli W.E. Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease. Atherosclerosis 154 (2001) 147-154
79. Stern L.L., Mason J.B., Selhub J., and Choi S.W. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 9 (2000) 849-853